drugset / Trial / NCT04363203

VA Remote and Equitable Access to COVID-19 Healthcare Delivery (VA-REACH TRIAL)

NCT04363203

RandomizedSingle-groupQuadruple-blindTreatment

Summary

We propose a 3-arm RCT to determine the efficacy of hydroxychloroquine or azithromycin in treating mild to moderate COVID-19 among Veterans in the outpatient setting.

Timeline

Start
2020-04-30
Primary completion
2021-03
Completion
2021-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 250 mg Oral
Comparator Hydroxychloroquine Small molecule 200 mg Oral

Indications